Pradaxa 150 mg/1
dabigatran etexilate mesylate · CAPSULE · Boehringer Ingelheim Pharmaceuticals Inc.
Pradaxa (dabigatran) is an oral anticoagulant medication used to help prevent blood clots and reduce the risk of stroke in patients with atrial fibrillation, and it may also be prescribed to treat or prevent deep vein thrombosis and pulmonary embolism. This medication works by inhibiting thrombin, an enzyme involved in blood clot formation.
Key Facts
- Brand Name
- Pradaxa
- Generic Name
- dabigatran etexilate mesylate
- NDC Code (Product)
0597-0360- Manufacturer
- Boehringer Ingelheim Pharmaceuticals Inc.
- Strength
- 150 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA022512
- Marketing Start
- 07/28/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Pradaxa used for?
Pradaxa (dabigatran) is an oral anticoagulant medication used to help prevent blood clots and reduce the risk of stroke in patients with atrial fibrillation, and it may also be prescribed to treat or prevent deep vein thrombosis and pulmonary embolism. This medication works by inhibiting thrombin, an enzyme involved in blood clot formation.
Is Pradaxa a controlled substance?
Pradaxa is not classified as a controlled substance by the DEA.
What is the generic name for Pradaxa?
The generic name for Pradaxa is dabigatran etexilate mesylate. There are no other listed brand versions of dabigatran etexilate mesylate.
What is the NDC code for Pradaxa 150 mg/1?
The NDC (National Drug Code) for Pradaxa 150 mg/1 is 0597-0360, listed by Boehringer Ingelheim Pharmaceuticals Inc..
Other Pradaxa Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)